Introduction
Microglia are believed to be the only resident immune cells in the central nervous system (CNS); they develop from hematopoietic-derived myeloid cells and invade the CNS during development (Ling & Wong, 1993) . Microglial cells are recognized to play an important role not only in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Alzheimer's disease but also in neuroprotective and anti-neuroinflammatory processes (Akiyama & McGeer, 2004; Sanders & De Keyser, 2007; Takahashi et al., 2007) . In a recent study, it has been reported that physiological microglial phagocytosis induced the efficient removal of apoptotic cells and cellular debris without inflammatory processes; this process is expected to be a novel, attractive target for protection from neuroinflammation or neurodegeneration (Takahashi et al., 2005 . The detailed mechanisms underlying the differentiation and transformation of microglial cells, however, are not fully understood. Even in adulthood, hematopoietic-derived cells develop into resident perivascular macrophages and microglia (Hickey & Kimura, 1988; Priller et al., 2001; Simard & Rivest, 2004) . Although the exact cellular subtype of myeloid precursors that develop into microglia is unknown, it has been reported 6 that only Ly-6C high CCR2+ monocytes can invade and differentiate into perivascular microglia (Mildner et al., 2007) .
The bone marrow produces new blood cells, including all cell types of the myeloid lineage, some of which may differentiate into microglia.
Lineage-negative bone marrow (LN) cells are defined by the absence of surface markers such as CD3, CD4, CD5, CD8α, CD11b/MAC-1α, B220, Gr-1, and TER-119 and are considered to comprise many hematopoietic precursors, including microglia precursors. Thus, LN cells might represent microglial precursors and may serve as a natural vehicle for CNS cells in gene therapy.
In this study, we show that murine microglial cells are present in vitro in 2 morphological forms, namely, as small round cells expressing CD11b, Iba1, triggering receptor expressing on myeloid cells-2 (TREM2), and weakly expressing major histocompatibility complex (MHC) class II and as large flat cells expressing only CD11b and Iba1. We found that LN cells could differentiate into the small round-type but not the large flat-type microglia-like cells.
Moreover, we concluded that not only macrophage colony-stimulating factor (M-CSF) but also cell-cell contacts with astrocytes play an important role in microglial differentiation. 7
Materials and Methods

Isolation of LN cells from adult GFP mice bone marrow
Bone marrow cells were collected from 8-to 10-week-old C57BL/6 mice (Charles River, Japan) or green fluorescence protein (GFP) transgenic mice on a C57BL/6 mice background that were kindly provided by Dr. Masaru Okabe (Osaka University, Japan) by flushing out the femora and tibiae of the hind limb.
Erythrocyte removal was performed by lysis with the Mouse Erythrocyte Lysing
Kit (R&D, Minneapolis, MN). For eliminating lineage marker-positive cells via negative selection, bone marrow cells were incubated at 4°C for 30 min with 8 types of rat monoclonal antibodies against mice lineage markers (CD3, CD4, CD5, CD8α, CD11b/MAC-1α, B220, Gr-1, and TER-119 (R&D)). The cells were then washed and incubated with immunomagnetic beads (Invitrogen, Tokyo, Japan) at 4°C for 30 min. Finally, LN cells were collected by the removal of lineage-positive bone marrow cells by using a magnet stand that attracted the lineage marker-positive cells attached to the antibodies. All experiments were approved by the Ethics Committee of Kanazawa University and performed in accordance with the guidelines of the local animal care and use committee of Kanazawa University.
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Primary mixed glial cell culture
Microglial cells were prepared from the brains of postnatal days 3-5 (P3-P5) of C57BL/6 mice as previously described (Takahashi et al., 2005) .
Briefly, meninges were removed mechanically, and the cells were dissociated by trituration and cultured in basal medium Eagle (BME; Invitrogen), 10% fetal calf serum (FCS; Invitrogen), 1% glucose (Sigma, Tokyo, Japan), 1% L-glutamine (Invitrogen), and 1% penicillin/streptomycin (Invitrogen) for 14 d to form a confluent glial monolayer. LN bone marrow cells obtained from GFP mice were added onto the confluent glial monolayer.
Treatment of LN cell culture with mixed glial cell culture supernatant, neutralizing antibodies, or cytokines LN cells were cultured with the mixed glial cell culture supernatant obtained from the day-14 primary mixed glial culture. LN cells were also cultured with a culture medium containing M-CSF (10 ng/ml, Peprotech, Rocky Hill, NJ), tumor necrosis factor-α (TNF-α; 10 ng/ml, Peprotech), or vascular endothelial growth factor (VEGF; 50 ng/ml, Peprotech) for 7 d. For the neutralizing assay, 9 anti-M-CSF (2 μg/ml, R&D), anti-TNF-α (2 μg/ml, R&D), or anti-VEGF (1 μg/ml, R&D) antibodies were added in the LN cell culture for 7 d.
Immunohistochemistry
Mixed glial cell cultures with or without GFP-positive (GFP+) LN cells were fixed in 4% paraformaldehyde for 1 h, blocked by Protein Block (Dako, Denmark) for 2 h, and then immunostained with monoclonal rat antibodies directed against CD11b (Serotec, Oxford, UK) and a secondary fluorescence rhodamine-conjugated antibody directed against rat IgG (1:200, Millipore, Billerica, MA). To identify the cell type, cells were double-labeled with a purified polyclonal sheep antibody directed against TREM2 (1:50, R&D), monoclonal rabbit antibodies directed against Iba1 (Wako, Kanagawa, Japan), and glial fibrillary acidic protein (GFAP; Dako) and monoclonal mouse antibodies directed against IAb (BD Pharmingen, Tokyo, Japan), followed by a secondary fluorescein isothiocyanate (FITC)-conjugated antibody directed against mouse IgG. Images were collected by fluorescence microscopy with a 20× objective (Olympus, Tokyo, Japan). A confocal microscope with a 40× objective (Zeiss, Jena, Germany) was used to obtain z-stack images, and series of optical sections 10 (512 × 512 pixels, pixel size: 440 nm) were collected at intervals of 380 nm.
Images were analyzed using the Zeiss LSM Image browser (Zeiss).
To quantify the number of cells, 10 fields under the 20× objective were randomly selected and photographed by fluorescence microscopy using a digital camera (Olympus) for each experiment. Total cells, GFP-positive cells, and positively immunostained cells were classified and counted according to their morphology.
Isolation of microglia and splenic macrophages
Microglial cells and GFP+ LN cells-derived microglial cells in primary mixed glial culture were obtained by shaking the flasks at 150 rpm for 2 h.
Adult CNS microglia and splenic macrophages were obtained from GFP mice.
The cortex and spinal cord of GFP mice were isolated and homogenized.
Homogenates were incubated with 0.3 Wunsch units/ml Liberase Blendzyme 3 (Roche, Tokyo, Japan) and 0.1 mg/ml DNaseI (Roche) in RPMI 1640 medium at 37°C for 30 min. Microglia were separated through a density gradient. The cells were suspended in 27% Percoll (GE Healthcare, Tokyo, Japan) and overlaid with a 72% gradient. The density gradient was centrifuged at 2,800 rpm for 30 min at 4°C. Myelin collected in the 27% Percoll layer was removed. The majority of microglia were found in the interface of the 27% and 72% Percoll layers. Cells were obtained from this interface and washed from the Percoll with phosphate buffered saline (PBS). The spleen was isolated and cut into small fragments. Cells were incubated with 0.3 Wunsch units/ml Liberase Blendzyme 3 (Roche) and 0.1 mg/ml DNaseI (Roche) in RPMI 1640 medium at 37°C for 45 min. Erythrocyte removal was performed using ACK solution.
Flow cytometry analysis of LN cells, microglia, and splenic macrophages
For flow cytometry analysis, cells were first incubated for Fc-receptor blockade by CD16/CD32 antibody (BD Pharmingen) and then stained with PE-conjugated anti-IAb antibody and anti-CD45 antibody (BD Pharmingen), PerCP-Cy5.5-conjugated anti-CD11b antibody (BD Pharmingen), APC-conjugated anti-TREM2 antibody (R&D) and anti-F4/80 antibody (eBioscience, San Diego, CA), or purified anti-CCR2 antibody (Abcam, Tokyo, Japan) followed by rhodamine-conjugated anti-Goat IgG (Millipore, Billerica, MA). Analysis was performed with a FACSCalibur flow cytometer (BD Biosciences, Tokyo, Japan).
Proliferation assay
Microglial cells and GFP+ LN cells-derived microglia-like cells in primary mixed glial culture, adult CNS microglia, and splenic macrophages were cultured with various concentrations of M-CSF (0-100 ng/ml), and cultures were pulsed with 1 mCi of [ 3 H]TdR (MP Biomedicals, Tokyo, Japan) for the last 16 h of the incubation. Cell incorporation of [ 3 H]TdR was counted with a Topcount (Perkin Elmer, Boston, MA). The mean cpm of triplicate cultures was calculated.
Stimulation by anti-TREM2 antibody
Small round cells were added to culture dishes coated with the anti-TREM2 monoclonal antibody (R&D) or control antibody and centrifuged at 1500 rpm for 5 min. After 60 min, the cells were fixed at a final concentration of 4% formaldehyde for 10 min at 37 °C. Following centrifugation, the supernatant was removed, and the cells were resuspended in 90% ice-cold methanol and incubated for 30 min at 4°C. Cells were washed and stained with Alexa 647-conjugated anti-phospho-ERK1/2 antibody (Cell Signaling Technology, Tokyo, Japan) for 30 min. Analysis was performed using a 13 FACSCalibur flow cytometer.
Bio-Plex Cytokine Assay System
Culture added to each well, followed by 30-min incubation again. The plate was washed, and 50 μl of streptavidin-conjugated phycoerythrin (PE; Bio-Rad) was added to each well and incubated for 10 min. After a final wash, the contents of each well were resuspended in 125 μl of assay buffer (Bio-Rad) and analyzed using a Bio-Plex Array Reader (Bio-Rad). The lower detection limit for each cytokine or chemokine was 2 pg/ml.
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Statistical analysis
Data are presented as mean ± S.D. of at least three independent experiments. Data were analyzed by the Mann-Whitney U test to determine significant differences.
Results
Characterization of microglia in the primary mixed glial culture
To characterize microglial cells in the mixed glial culture, we stained several microglia markers such as Iba1, CD11b, TREM2, and IAb (MHC class II molecule of C57/BL6 mice) on the cultured microglial cells (Fig. 1A ).
CD11b-positive (CD11b+) cells in the primary mixed glial culture showed two major morphological forms, namely, small round-shaped cells (32.8 ± 6.9% S.D.
of CD11b+ Iba1 vs. TREM2, P = 0.0495; Iba1 vs. IAb, P = 0.0495) ( Fig. 1B, C) .
Z-sectioned scans by confocal microscopy revealed that small, spherically shaped cells lay above the astrocytes, and large flat cells lay under the astrocytes (Fig.   1D ). Moreover, the spherical cells appeared to have extended processes toward the astrocytes (Fig. 1E) .
To investigate the time point at which both the forms of the microglial cells appeared in the primary mixed glial culture, we performed a kinetic study. At day 1 after the culture of mixed glial cells, CD11b+ cells showed a small amoeboid shape (Fig. 1F) . At day 3, the CD11b+ cells assumed a larger flat shape. Small round CD11b+ cells were very few in number until day 5 (day 3, 1.9 ± 1.1% S.D.; day 5, 2.7 ± 0.9% S.D.) but increased greatly after day 7 (day 7, 10.9 ± 1.1% S.D., vs. day 3, P = 0.0495; day 14, 32.8 ± 6.9% S.D., vs. day 3, P = 0.0495) ( Fig. 1F, G) .
Characteristics of LN cells
LN cells were isolated by negative selection using magnet beads. The purity of LN cells after negative selection by flow cytometry was consistently above 90% on several examinations ( Fig. 2A ). LN cells expressed neither the microglia marker TREM2 nor CD11b, which is one of the lineage markers for negative selection (Fig. 2B ). No expression of CCR2 or Gr-1 (lineage markers for negative selection) was detected on the LN cells, which have previously been described as markers of microglial precursors (Fig. 2B ). IAb, which is an MHC class II antigen, was negative on the surface of the LN cells.
Differentiation of LN cells into microglia-like cells
LN cells obtained from GFP mice were co-cultured with primary mixed glial cells for 2 weeks. Two weeks after the co-culture, the cells were stained by anti-TREM2, anti-Iba1, anti-MHC class II, and anti-CD11b antibodies, followed by rhodamine-or Cy3-conjugated secondary antibodies (Fig. 3A) . GFP+ cells showed 2 major morphologies, i.e., small and round cells with bright nuclei (27.7 ± 7.9% S.D. in GFP+ cells) and flat cells with dark nuclei (69.9 ± 6.9% S.D. in GFP+ cells), similar to the microglia in the primary mixed glial cells seen in Fig.   1 . Most of the small round cells were TREM2-, Iba1-, CD11b-, and IAb-positive (TREM2+ cells, 92.7 ± 1.9% S.D.; Iba1+ cells, 93.6 ± 1.6% S.D.; CD11b+ cells, 96.5 ± 3.1% S.D.; IAb+ cells, 84.6 ± 13.4% S.D.) ( Fig. 3B ) and were spherically shaped along the z-axis (Fig. 3C ). On the other hand, flat cells expressed none of the following: CD11b, Iba1, TREM2, or IAb (TREM2+ cells, 6.5 ± 3.9% S.D.;
Iba1+ cells, 3.5 ± 1.0% S.D.; CD11b+ cells, 9.3 ± 3.7% S.D.; IAb+ cells, 3.9 ± 1.9% S.D.). Since TREM2/DAP12 signaling is known to induce ERK phosphorylation in immature dendritic cells, we analyzed the (Fig. 3D) .
In the kinetic study, GFP+ LN cells were immunostained at days 1, 7, and 14 after co-culturing with primary mixed glial cells with anti-TREM2 and anti-Iba1 antibodies followed by secondary antibodies. At day 1, LN cells had already differentiated into 2 morphological groups-small round cells expressing Iba1 and TREM2 and flat amoeboid cells (Fig. 3E) . Interestingly, the ratio of LN cell-derived small round and flat cells remained identical at day 1 and day 7 but reduced at day 14 (day 1, 45.7 ± 2.5% S.D.; day 7, 41.7 ± 1.9% S.D., vs. day 1, P = 0.0495; day 14, 29.5 ± 6.4% S.D., vs. day 1, P = 0.0495) (Fig. 3F) .
Analysis of surface cell markers and proliferative capacity of LN cell-derived small round cells
In many publications, not only the expression of CD11b, Iba1, and F4/80 but also low expressions of CD45 and MHC class II have been used as microglial markers. Among them, low expressions of CD45 and MHC class II are one of the most important resting microglial markers. We measured the quantitative expression of CD45 and MHC class II on brain microglia, cultured microglia, and LN cell-derived small round cells. As shown in Figure 4A , LN cell-derived small round cells showed low expressions of CD45 and MHC class II, which was identical to results for cultured and brain microglia as compared to those for spleen-derived macrophages. LN cell-derived small round cells were also F4/80 positive, which is known to be another microglial marker.
Since microglia can continue to proliferate and differentiate to macrophages, we investigated the proliferative capacity of brain microglia and LN cell-derived small round cells with various concentrations of M-CSF, and compared this capacity to that of splenic macrophages. LN cell-derived small round cells showed increased incorporation of [ 3 H] thymidine similar to that by brain microglia, but [ 3 H] thymidine incorporation by splenic macrophages did not increase in a low concentration of M-CSF (1 ng/ml) (LN cell-derived small round cells vs. splenic macrophages, P = 0.0495; brain microglia vs. splenic macrophages, P = 0.0495) (Fig. 4B) .
These results indicate that small round cells and microglia are similar in terms of their cell surface molecules and the proliferative capacity. 5C ). Morphologically, most LN-MCSF cells showed flat shapes on confocal microscopy (Fig. 5D ). The number of LN cells cultured with TNF-α (LN-TNF cells) or with VEGF (LN-VEGF cells) were very few, although these cells expressed CD11b and TREM2 (Fig. 5C ).
Next, LN cells were cultured with the mixed glial culture supernatant containing neutralizing antibodies of M-CSF, TNF-α, or VEGF. Addition of the anti-VEGF antibody or anti-TNF-α antibody resulted in no change in the morphology or surface markers as compared with the culture containing the control antibodies; however, the addition of anti-M-CSF antibodies remarkably reduced the cell number despite the expression of TREM2 (Fig. 5C ).
Cell-to-cell contact between microglia and astrocytes 22
In order to reveal the role of cell-to-cell contact between microglia and other glial cells, especially astrocytes, in the differentiation of LN cells to microglia, we performed immunostaining of the mixed glial culture with LN cells by anti-GFAP antibody followed by secondary rhodamine-conjugated antibody against rabbit-IgG. Analysis by confocal microscopy revealed that LN cell-derived small round cells were positioned above the GFAP-positive astrocytes (Fig. 6 ).
On the other hand, large flat cells lay immediately beneath the GFAP-positive astrocytes.
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Discussion
Microglia, the immune cells of the CNS, exist in 3 distinct forms-amoeboid, ramified, and reactive microglia. Ramified microglia are present in the brain parenchyma and constitute approximately 10-20% of the total population of glial cells in an adult (Vaughan & Peters, 1974; Banati, 2003) . Ramified microglia are small round cells comprising branching processes and are considered to be functionally inactive. Further, they are known to express TREM2 in vivo (Schmid et al., 2002; Sessa et al., 2004) but not MHC class II (Santambrogio et al., 2001; Servet-Delprat et al., 2002) . Recently, HSP60 has been identified as the ligand of TREM2, and its interaction with microglia has been demonstrated to stimulate microglial phagocytosis (Stefano et al., 2009 ). This result indicates that TREM2 might play an important role in physiological phagocytosis as one of the microglia-specific functions. TREM2 expression on small round cells in primary mixed glial culture might indicate that small round cells have greater mobility as microglia than do large flat cells in patrolling the brain environment in order to identify HSP60-expressing cells. Moreover, as shown in Figure 4A , small round cells weakly expressed MHC class II molecules similar to brain microglia. These results support our hypothesis that small round microglia in 24 vitro differentiated to a greater extent than did large flat cells. Consistent with the results of the current study, previous studies have reported 2 different morphological shapes of microglia in primary mixed glial culture cells derived from mice (Saura et al., 2003) and rats (Tanaka et al., 1999; Kuwabara et al., 2003) . In another study, the kinetic analysis of rat primary mixed glial culture demonstrated that "amoeboid" or "round" cells appeared during the early stages of the culture and that the majority of ramified microglia were formed after the complete formation of the astrocyte monolayer (Tanaka et al., 1999) . We demonstrated that LN cells directly differentiated into small round microglia-like cells without the intermediary formation of large flat precursors. Although
Ly-6C high Gr-1+CCR2+ monocytes in the peripheral blood have been reported to be the precursors of adult murine microglia (Mildner et al., 2007; Getts et al., 2008) , the LN cells in our study did not express CCR2 or Gr-1 (the anti-Gr-1 antibodies used in this study also reacted with Ly-6C). The role of CCR2, a crucial chemokine receptor for the chemotactic attraction of monocytes or macrophages during CNS inflammation, has been investigated in animal models of multiple sclerosis, such as experimental autoimmune encephalomyelitis (Fife et al., 2000; Izikson et al., 2000) . However, the physiological development and functions of microglia are independent of CCR2 expression (Mildner et al., 2007) .
Since the absence of CCR2 expression is highly related to the Ly-6C high subpopulation (Mildner et al., 2007) , Ly-6C may play a more important role than CCR2 in microglial differentiation. It is unclear why the LN cells differentiated into small round microglia-like cells despite the lack of Ly-6C and Gr-1 expression, but we hypothesize that the blood-brain barrier plays a key role in the differentiation of LN cells. Indeed, Ly-6C is known to regulate endothelial adhesion and the homing of CD8+T cells by activating integrin-dependent adhesion pathways (Hänninen et al., 1997) .
On the other hand, the LN cells in the current study did not differentiate into flat cells as the precursors of small round microglia. Since they were first described by del Rio-Hortega (1932) , the developmental origin of microglia has not been completely elucidated. It is widely hypothesized that microglia are derived from myeloid lineage precursors and/or hematopoietic precursors during CNS development. The fact that the formation of microglia occurs before the onset of vascularization in the developing brain (Wang et al., 1996) suggests that hematopoietic stem cells, which act as precursors to microglia during development, may be more primitive than precursor LN cells. Therefore, it is likely that the LN cells adopt a different pathway to differentiate into small round microglia-like cells.
The supernatant of the primary mixed glial cultures derived from mice contains many cytokines such as M-CSF, VEGF, and TNF-α. Our study showed that M-CSF plays an important role in the differentiation and proliferation of LN cells. TREM2 is a unique molecule that is only expressed on microglia, osteoclasts, and immature dendritic cells (Colonna, 2003) , while other microglia-specific markers such as Iba1 and CD11b are also expressed on macrophages and monocytes. Since TREM2 was not expressed on the mature dendritic cells or the activated microglia (macrophages), it is likely that TREM2 expression may be restricted to the immature stages of myeloid lineage cells. In Z-stack immunofluorescence confocal microscopy of lineage-negative bone marrow cells derived from GFP mice co-cultured with primary mixed glial culture stained with anti-GFAP (red) and DAPI (blue). Bar: 10 μm.
